GSK announced positive results from two Phase III trials of depemokimab for treating chronic rhinosinusitis with nasal polyps in adults. The trials demonstrated significant improvements in nasal polyp size and obstruction with twice-yearly administration of the antibody compared to placebo.
Read MoreDid you find this insightful?
Amazing
Bad
Just Okay